NEW YORK (GenomeWeb News) – Cancer Research UK said yesterday that it has launched a multicenter personalized medicine project with industrial partners Pfizer and AstraZeneca that will seek to demonstrate how genetic tests could be used to match cancer patients to the treatments that work best for them.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.